Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam.
Saved in:
| Title: | Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam. |
|---|---|
| Authors: | Tamma PD; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Immel S; Department of Medicine, National Institutes of Health, Bethesda, Maryland, USA., Karaba SM; Department of Medicine, Johns Hopkins University of Medicine, Baltimore, Maryland, USA., Soto CL; Department of Pharmacy, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Conzemius R; Ares Genetics, Vienna, Austria., Gisriel E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tekle T; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Stambaugh H; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Johnson E; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tornheim JA; Department of Medicine, Johns Hopkins University of Medicine, Baltimore, Maryland, USA., Simner PJ; Department of Medicine, Johns Hopkins University of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 15; Vol. 79 (4), pp. 819-825. |
| Publication Type: | Journal Article; Case Reports; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
